The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Three vs. 1 year of adjuvant imatinib (IM) for operable high-risk GIST: The second planned analysis of the randomized SSGXVIII/AIO trial.
 
Heikki Joensuu
Stock and Other Ownership Interests - Orion
Honoraria - ARIAD; Blueprint Medicines; Orion
Consulting or Advisory Role - ARIAD; Blueprint Medicines; Orion
 
Mikael Eriksson
Honoraria - Bayer; Bayer
Consulting or Advisory Role - Isofol Medical
Travel, Accommodations, Expenses - GlaxoSmithKline; Swedish Orphan Biovitrum; Swedish Orphan Biovitrum
 
Kirsten Sundby Hall
Patents, Royalties, Other Intellectual Property - Inven2 (I)
Expert Testimony - Novartis (I)
 
Annette Reichardt
Honoraria - Amgen; Bayer; GlaxoSmithKline; Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - Amgen; ARIAD; Bayer; GlaxoSmithKline; Novartis; Pfizer; PharmaMar
Research Funding - Novartis
 
Giuliano Ramadori
No Relationships to Disclose
 
Peter Hohenberger
Honoraria - Bayer; Novartis
Consulting or Advisory Role - Bayer; Novartis
Research Funding - Novartis; Pfizer
 
Salah-Eddin Al-Batran
Honoraria - Lilly; Roche
Consulting or Advisory Role - Lilly; Roche
Research Funding - Celgene; Novartis; Roche Pharma AG; Sanofi
 
Marcus Schlemmer
Honoraria - Novartis; Pfizer; Teva
Consulting or Advisory Role - Novartis; Teva (Inst)
 
Sebastian Bauer
Consulting or Advisory Role - Blueprint Medicines; GlaxoSmithKline; Novartis; Pfizer
 
Daniel Pink
No Relationships to Disclose
 
Justus Duyster
Consulting or Advisory Role - Gilead Sciences; Novartis (I)
 
Bengt E. Nilsson
No Relationships to Disclose
 
Odd R Monge
No Relationships to Disclose
 
Raija Kallio
No Relationships to Disclose
 
Petri Bono
Honoraria - GlaxoSmithKline; Novartis; Pfizer
Consulting or Advisory Role - Orion
 
Jouni Junnila
No Relationships to Disclose
 
Eva Wardelmann
Honoraria - Nanobiotix; Novartis; Pfizer
Consulting or Advisory Role - Nanobiotix
Research Funding - Novartis
Travel, Accommodations, Expenses - Nanobiotix; Novartis; Pfizer
 
Thor Alvegard
No Relationships to Disclose
 
Peter Reichardt
Honoraria - Amgen; Bayer; GlaxoSmithKline; Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - Amgen; ARIAD; Bayer; GlaxoSmithKline; Novartis; Pfizer; PharmaMar
Research Funding - Novartis (Inst)